Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma.

Arshad A PandithIqbal QasimShahid M BabaAabid KoulWani ZahoorDil AfrozeAdil LateefUsma ManzoorIna A BhatDheera SanadhyaAbdul R BhatAltaf U RamzanFozia MohammadIqra Anwar

Published in: Future science OA (2020)

IDH1/2 mutations proved independent prognostic factors in glioma and associated with MGMT methylation for better survival.

Keyphrases

prognostic factors
genome wide
dna methylation
low grade
copy number
gene expression
wild type
transcription factor
genome wide identification